The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo.
Menegazzo L, Scattolini V, Cappellari R, Bonora BM, Albiero M, Bortolozzi M, Romanato F, Ceolotto G, Vigili de Kreutzeberg S, Avogaro A, Fadini GP.
Menegazzo L, et al. Among authors: fadini gp.
Acta Diabetol. 2018 Jun;55(6):593-601. doi: 10.1007/s00592-018-1129-8. Epub 2018 Mar 15.
Acta Diabetol. 2018.
PMID: 29546579
Clinical Trial.